nodes	percent_of_prediction	percent_of_DWPC	metapath
Phylloquinone—BGLAP—asthma	0.817	1	CbGaD
Phylloquinone—Vitamin E—PPP2CA—asthma	0.00427	0.44	CrCbGaD
Phylloquinone—Phlebitis—WF10—asthma	0.00323	0.0257	CcSEcCtD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—SFTPD—asthma	0.00306	0.0643	CbGpPWpGaD
Phylloquinone—Injection site pain—Terbutaline—asthma	0.00295	0.0235	CcSEcCtD
Phylloquinone—BGLAP—Osteoblast Signaling—PDGFB—asthma	0.0029	0.0609	CbGpPWpGaD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—DCN—asthma	0.00263	0.0552	CbGpPWpGaD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—TBX21—asthma	0.00257	0.054	CbGpPWpGaD
Phylloquinone—BGLAP—Notch-mediated HES/HEY network—MYB—asthma	0.00239	0.0502	CbGpPWpGaD
Phylloquinone—Vitamin E—HMOX1—asthma	0.00218	0.225	CrCbGaD
Phylloquinone—Hyperbilirubinaemia—Zileuton—asthma	0.00218	0.0173	CcSEcCtD
Phylloquinone—Hyperbilirubinaemia—Zafirlukast—asthma	0.00188	0.0149	CcSEcCtD
Phylloquinone—BGLAP—Notch-mediated HES/HEY network—PARP1—asthma	0.00175	0.0367	CbGpPWpGaD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—HMOX1—asthma	0.00166	0.0349	CbGpPWpGaD
Phylloquinone—GGCX—Post-translational protein modification—MUC7—asthma	0.00162	0.0339	CbGpPWpGaD
Phylloquinone—Atrophy—Prednisolone—asthma	0.0015	0.0119	CcSEcCtD
Phylloquinone—Atrophy—Hydrocortisone—asthma	0.00146	0.0116	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Orciprenaline—asthma	0.00146	0.0116	CcSEcCtD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—DNMT1—asthma	0.00141	0.0295	CbGpPWpGaD
Phylloquinone—Swelling—Zafirlukast—asthma	0.0014	0.0111	CcSEcCtD
Phylloquinone—Atrophy—Triamcinolone—asthma	0.00137	0.0109	CcSEcCtD
Phylloquinone—Atrophy—Methylprednisolone—asthma	0.00137	0.0109	CcSEcCtD
Phylloquinone—Phlebitis—Theophylline—asthma	0.00137	0.0109	CcSEcCtD
Phylloquinone—Sweating—Isoprenaline—asthma	0.00134	0.0107	CcSEcCtD
Phylloquinone—Inflammation—Ipratropium bromide—asthma	0.00133	0.0106	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—IL13—asthma	0.00131	0.0275	CbGpPWpGaD
Phylloquinone—Sweating—Terbutaline—asthma	0.00129	0.0103	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAU—asthma	0.00129	0.0271	CbGpPWpGaD
Phylloquinone—Inflammation—Salmeterol—asthma	0.00128	0.0102	CcSEcCtD
Phylloquinone—Swelling—Ciclesonide—asthma	0.00128	0.0102	CcSEcCtD
Phylloquinone—Atrophy—Dexamethasone—asthma	0.00125	0.00991	CcSEcCtD
Phylloquinone—Atrophy—Betamethasone—asthma	0.00125	0.00991	CcSEcCtD
Phylloquinone—GGCX—Post-translational protein modification—MUC5AC—asthma	0.00122	0.0257	CbGpPWpGaD
Phylloquinone—Anaphylactoid reaction—Theophylline—asthma	0.00122	0.00967	CcSEcCtD
Phylloquinone—Flushing—Dyphylline—asthma	0.0012	0.00955	CcSEcCtD
Phylloquinone—Vitamin E—NQO1—asthma	0.0012	0.123	CrCbGaD
Phylloquinone—Sweating increased—Orciprenaline—asthma	0.00119	0.00942	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—GATA3—asthma	0.00118	0.0248	CbGpPWpGaD
Phylloquinone—Flushing—Isoprenaline—asthma	0.00117	0.00928	CcSEcCtD
Phylloquinone—Swelling—Cromoglicic acid—asthma	0.00116	0.00922	CcSEcCtD
Phylloquinone—Vitamin E—ALOX5—asthma	0.00116	0.12	CrCbGaD
Phylloquinone—Flushing—Terbutaline—asthma	0.00112	0.00892	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—IL5—asthma	0.00112	0.0235	CbGpPWpGaD
Phylloquinone—Injection site pain—Formoterol—asthma	0.0011	0.00875	CcSEcCtD
Phylloquinone—Injection site pain—Arformoterol—asthma	0.0011	0.00875	CcSEcCtD
Phylloquinone—Atrophy—Prednisone—asthma	0.00109	0.00863	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—asthma	0.00107	0.0225	CbGpPWpGaD
Phylloquinone—Swelling—Ipratropium bromide—asthma	0.00106	0.00843	CcSEcCtD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—ICAM1—asthma	0.00104	0.0219	CbGpPWpGaD
Phylloquinone—Sweating—Orciprenaline—asthma	0.00104	0.00827	CcSEcCtD
Phylloquinone—Swelling—Salmeterol—asthma	0.00102	0.00814	CcSEcCtD
Phylloquinone—Phlebitis—Aminophylline—asthma	0.000996	0.00791	CcSEcCtD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—CSF2—asthma	0.000963	0.0202	CbGpPWpGaD
Phylloquinone—BGLAP—FGF signaling pathway—PLAU—asthma	0.000955	0.0201	CbGpPWpGaD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—asthma	0.000954	0.02	CbGpPWpGaD
Phylloquinone—Anaphylactoid reaction—Fluticasone Propionate—asthma	0.000936	0.00743	CcSEcCtD
Phylloquinone—Inflammation—Formoterol—asthma	0.000928	0.00737	CcSEcCtD
Phylloquinone—Inflammation—Arformoterol—asthma	0.000928	0.00737	CcSEcCtD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—PPP2CA—asthma	0.000897	0.0188	CbGpPWpGaD
Phylloquinone—Immune system disorder—Indacaterol—asthma	0.000887	0.00704	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Aminophylline—asthma	0.000887	0.00704	CcSEcCtD
Phylloquinone—Vitamin E—GSTP1—asthma	0.000885	0.0913	CrCbGaD
Phylloquinone—Flushing—Pirbuterol—asthma	0.00088	0.00699	CcSEcCtD
Phylloquinone—Inflammation—Salbutamol—asthma	0.000876	0.00696	CcSEcCtD
Phylloquinone—Hyperhidrosis—Isoprenaline—asthma	0.000865	0.00687	CcSEcCtD
Phylloquinone—Hypotension—Dyphylline—asthma	0.00086	0.00683	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CXCL8—asthma	0.000846	0.0178	CbGpPWpGaD
Phylloquinone—Hypotension—Isoprenaline—asthma	0.000836	0.00664	CcSEcCtD
Phylloquinone—Hyperhidrosis—Terbutaline—asthma	0.000831	0.0066	CcSEcCtD
Phylloquinone—Immune system disorder—Fluticasone furoate—asthma	0.000824	0.00654	CcSEcCtD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—CDK2—asthma	0.000813	0.0171	CbGpPWpGaD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—CSF2—asthma	0.00081	0.017	CbGpPWpGaD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—BCL2—asthma	0.0008	0.0168	CbGpPWpGaD
Phylloquinone—Dyspnoea—Isoprenaline—asthma	0.000798	0.00633	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—IL4—asthma	0.000797	0.0167	CbGpPWpGaD
Phylloquinone—Dyspnoea—Terbutaline—asthma	0.000767	0.00609	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—MUC7—asthma	0.000766	0.0161	CbGpPWpGaD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—asthma	0.000765	0.0161	CbGpPWpGaD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—NR3C1—asthma	0.000758	0.0159	CbGpPWpGaD
Phylloquinone—Flushing—Theophylline—asthma	0.000757	0.00601	CcSEcCtD
Phylloquinone—BGLAP—Notch-mediated HES/HEY network—CD4—asthma	0.000726	0.0152	CbGpPWpGaD
Phylloquinone—Immune system disorder—Ciclesonide—asthma	0.000705	0.0056	CcSEcCtD
Phylloquinone—Anaphylactic shock—Orciprenaline—asthma	0.000693	0.0055	CcSEcCtD
Phylloquinone—Sweating—Ipratropium bromide—asthma	0.000691	0.00549	CcSEcCtD
Phylloquinone—Anaphylactic shock—Nedocromil—asthma	0.000678	0.00538	CcSEcCtD
Phylloquinone—Swelling—Budesonide—asthma	0.000677	0.00538	CcSEcCtD
Phylloquinone—Hyperhidrosis—Orciprenaline—asthma	0.000669	0.00532	CcSEcCtD
Phylloquinone—Anaphylactic shock—Fluticasone furoate—asthma	0.000648	0.00515	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—ICAM1—asthma	0.000633	0.0133	CbGpPWpGaD
Phylloquinone—Hypotension—Pirbuterol—asthma	0.000629	0.005	CcSEcCtD
Phylloquinone—Pain—Ketotifen—asthma	0.000625	0.00497	CcSEcCtD
Phylloquinone—Dyspnoea—Indacaterol—asthma	0.000622	0.00494	CcSEcCtD
Phylloquinone—Erythema—Cromoglicic acid—asthma	0.000617	0.0049	CcSEcCtD
Phylloquinone—Necrosis—Hydrocortisone—asthma	0.000606	0.00482	CcSEcCtD
Phylloquinone—Pain—Zileuton—asthma	0.000606	0.00481	CcSEcCtD
Phylloquinone—Dyspnoea—Nedocromil—asthma	0.000604	0.0048	CcSEcCtD
Phylloquinone—Flushing—Ipratropium bromide—asthma	0.000601	0.00477	CcSEcCtD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—STAT3—asthma	0.000592	0.0124	CbGpPWpGaD
Phylloquinone—Pain—Orciprenaline—asthma	0.000592	0.0047	CcSEcCtD
Phylloquinone—Dizziness—Isoprenaline—asthma	0.000592	0.0047	CcSEcCtD
Phylloquinone—Immune system disorder—Ipratropium bromide—asthma	0.000585	0.00464	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—MUC5AC—asthma	0.000581	0.0122	CbGpPWpGaD
Phylloquinone—Pain—Nedocromil—asthma	0.00058	0.0046	CcSEcCtD
Phylloquinone—Anaphylactic shock—Beclomethasone—asthma	0.000579	0.0046	CcSEcCtD
Phylloquinone—Anaphylactic shock—Theophylline—asthma	0.000579	0.0046	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—POMC—asthma	0.000579	0.0122	CbGpPWpGaD
Phylloquinone—Dyspnoea—Fluticasone furoate—asthma	0.000577	0.00459	CcSEcCtD
Phylloquinone—Necrosis—Methylprednisolone—asthma	0.00057	0.00452	CcSEcCtD
Phylloquinone—Dizziness—Terbutaline—asthma	0.000569	0.00452	CcSEcCtD
Phylloquinone—Immune system disorder—Fluticasone Propionate—asthma	0.000566	0.0045	CcSEcCtD
Phylloquinone—BGLAP—FGF signaling pathway—MMP9—asthma	0.000566	0.0119	CbGpPWpGaD
Phylloquinone—Immune system disorder—Salmeterol—asthma	0.000565	0.00448	CcSEcCtD
Phylloquinone—BGLAP—Notch-mediated HES/HEY network—STAT3—asthma	0.000562	0.0118	CbGpPWpGaD
Phylloquinone—Sweating—Flunisolide—asthma	0.000554	0.0044	CcSEcCtD
Phylloquinone—Flushing—Aminophylline—asthma	0.000551	0.00438	CcSEcCtD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—TGFB1—asthma	0.000549	0.0115	CbGpPWpGaD
Phylloquinone—Erythema—Fluticasone Propionate—asthma	0.000545	0.00433	CcSEcCtD
Phylloquinone—Hypotension—Theophylline—asthma	0.000541	0.0043	CcSEcCtD
Phylloquinone—Hypersensitivity—Zileuton—asthma	0.000522	0.00414	CcSEcCtD
Phylloquinone—Pain—Zafirlukast—asthma	0.00052	0.00413	CcSEcCtD
Phylloquinone—Sweating increased—Salbutamol—asthma	0.000519	0.00412	CcSEcCtD
Phylloquinone—Necrosis—Dexamethasone—asthma	0.000518	0.00411	CcSEcCtD
Phylloquinone—Necrosis—Betamethasone—asthma	0.000518	0.00411	CcSEcCtD
Phylloquinone—Hypersensitivity—Indacaterol—asthma	0.000514	0.00408	CcSEcCtD
Phylloquinone—Hypersensitivity—Orciprenaline—asthma	0.00051	0.00405	CcSEcCtD
Phylloquinone—Immune system disorder—Loratadine—asthma	0.000507	0.00402	CcSEcCtD
Phylloquinone—Immune system disorder—Tiotropium—asthma	0.000506	0.00402	CcSEcCtD
Phylloquinone—Anaphylactic shock—Cromoglicic acid—asthma	0.000504	0.004	CcSEcCtD
Phylloquinone—BGLAP—FGF signaling pathway—STAT3—asthma	0.000503	0.0106	CbGpPWpGaD
Phylloquinone—Sweating increased—Budesonide—asthma	0.000503	0.00399	CcSEcCtD
Phylloquinone—Hypersensitivity—Nedocromil—asthma	0.000499	0.00397	CcSEcCtD
Phylloquinone—Pain—Beclomethasone—asthma	0.000495	0.00393	CcSEcCtD
Phylloquinone—Dyspnoea—Ciclesonide—asthma	0.000494	0.00392	CcSEcCtD
Phylloquinone—Inflammation—Hydrocortisone—asthma	0.000491	0.0039	CcSEcCtD
Phylloquinone—Dizziness—Ketotifen—asthma	0.000484	0.00384	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—IFNG—asthma	0.000481	0.0101	CbGpPWpGaD
Phylloquinone—Hypersensitivity—Fluticasone furoate—asthma	0.000477	0.00379	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—asthma	0.000475	0.00999	CbGpPWpGaD
Phylloquinone—Hypotension—Cromoglicic acid—asthma	0.000471	0.00374	CcSEcCtD
Phylloquinone—Dizziness—Zileuton—asthma	0.000468	0.00372	CcSEcCtD
Phylloquinone—Dizziness—Indacaterol—asthma	0.000461	0.00366	CcSEcCtD
Phylloquinone—Inflammation—Methylprednisolone—asthma	0.000461	0.00366	CcSEcCtD
Phylloquinone—Anaphylactic shock—Ipratropium bromide—asthma	0.00046	0.00365	CcSEcCtD
Phylloquinone—Dizziness—Orciprenaline—asthma	0.000458	0.00364	CcSEcCtD
Phylloquinone—Sweating—Salbutamol—asthma	0.000456	0.00362	CcSEcCtD
Phylloquinone—Necrosis—Prednisone—asthma	0.000451	0.00358	CcSEcCtD
Phylloquinone—Dyspnoea—Cromoglicic acid—asthma	0.000449	0.00357	CcSEcCtD
Phylloquinone—Dizziness—Nedocromil—asthma	0.000448	0.00356	CcSEcCtD
Phylloquinone—Hypersensitivity—Zafirlukast—asthma	0.000448	0.00356	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—CXCL8—asthma	0.000448	0.0094	CbGpPWpGaD
Phylloquinone—Dizziness—Pirbuterol—asthma	0.000445	0.00354	CcSEcCtD
Phylloquinone—Anaphylactic shock—Fluticasone Propionate—asthma	0.000445	0.00354	CcSEcCtD
Phylloquinone—Hyperhidrosis—Ipratropium bromide—asthma	0.000445	0.00353	CcSEcCtD
Phylloquinone—Anaphylactic shock—Salmeterol—asthma	0.000444	0.00353	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—SLC30A8—asthma	0.00044	0.00925	CbGpPWpGaD
Phylloquinone—Immune system disorder—Mometasone—asthma	0.000435	0.00345	CcSEcCtD
Phylloquinone—Pain—Cromoglicic acid—asthma	0.000431	0.00342	CcSEcCtD
Phylloquinone—Hypotension—Ipratropium bromide—asthma	0.00043	0.00341	CcSEcCtD
Phylloquinone—Dizziness—Fluticasone furoate—asthma	0.000428	0.0034	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—IL2—asthma	0.000428	0.00899	CbGpPWpGaD
Phylloquinone—Hypersensitivity—Theophylline—asthma	0.000427	0.00339	CcSEcCtD
Phylloquinone—Anaphylactic shock—Aminophylline—asthma	0.000422	0.00335	CcSEcCtD
Phylloquinone—Dyspnoea—Ipratropium bromide—asthma	0.00041	0.00326	CcSEcCtD
Phylloquinone—Immune system disorder—Arformoterol—asthma	0.000408	0.00324	CcSEcCtD
Phylloquinone—Immune system disorder—Formoterol—asthma	0.000408	0.00324	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—PLA2G7—asthma	0.000403	0.00846	CbGpPWpGaD
Phylloquinone—Dizziness—Zafirlukast—asthma	0.000402	0.0032	CcSEcCtD
Phylloquinone—Immune system disorder—Montelukast—asthma	0.0004	0.00317	CcSEcCtD
Phylloquinone—Anaphylactic shock—Loratadine—asthma	0.000398	0.00316	CcSEcCtD
Phylloquinone—Dyspnoea—Fluticasone Propionate—asthma	0.000397	0.00315	CcSEcCtD
Phylloquinone—Dyspnoea—Salmeterol—asthma	0.000396	0.00314	CcSEcCtD
Phylloquinone—Flushing—Salbutamol—asthma	0.000396	0.00314	CcSEcCtD
Phylloquinone—Hypotension—Aminophylline—asthma	0.000394	0.00313	CcSEcCtD
Phylloquinone—Pain—Ipratropium bromide—asthma	0.000393	0.00312	CcSEcCtD
Phylloquinone—Immune system disorder—Salbutamol—asthma	0.000385	0.00306	CcSEcCtD
Phylloquinone—Flushing—Budesonide—asthma	0.000384	0.00305	CcSEcCtD
Phylloquinone—Dizziness—Beclomethasone—asthma	0.000383	0.00304	CcSEcCtD
Phylloquinone—Dizziness—Theophylline—asthma	0.000383	0.00304	CcSEcCtD
Phylloquinone—Pain—Fluticasone Propionate—asthma	0.000381	0.00302	CcSEcCtD
Phylloquinone—Pain—Salmeterol—asthma	0.00038	0.00302	CcSEcCtD
Phylloquinone—Immune system disorder—Budesonide—asthma	0.000373	0.00296	CcSEcCtD
Phylloquinone—Hypotension—Loratadine—asthma	0.000372	0.00296	CcSEcCtD
Phylloquinone—Hypersensitivity—Cromoglicic acid—asthma	0.000371	0.00295	CcSEcCtD
Phylloquinone—Dizziness—Ciclesonide—asthma	0.000366	0.00291	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Prednisolone—asthma	0.000365	0.0029	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Hydrocortisone—asthma	0.000357	0.00283	CcSEcCtD
Phylloquinone—Hyperhidrosis—Flunisolide—asthma	0.000356	0.00283	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—CMA1—asthma	0.000348	0.00731	CbGpPWpGaD
Phylloquinone—Anaphylactic shock—Mometasone—asthma	0.000342	0.00272	CcSEcCtD
Phylloquinone—Pain—Loratadine—asthma	0.000341	0.00271	CcSEcCtD
Phylloquinone—Hypersensitivity—Ipratropium bromide—asthma	0.000339	0.00269	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Triamcinolone—asthma	0.000336	0.00267	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Methylprednisolone—asthma	0.000335	0.00266	CcSEcCtD
Phylloquinone—Dizziness—Cromoglicic acid—asthma	0.000333	0.00264	CcSEcCtD
Phylloquinone—Dyspnoea—Flunisolide—asthma	0.000329	0.00261	CcSEcCtD
Phylloquinone—Hypersensitivity—Fluticasone Propionate—asthma	0.000328	0.00261	CcSEcCtD
Phylloquinone—Hypersensitivity—Salmeterol—asthma	0.000327	0.0026	CcSEcCtD
Phylloquinone—Anaphylactic shock—Arformoterol—asthma	0.000321	0.00255	CcSEcCtD
Phylloquinone—Anaphylactic shock—Formoterol—asthma	0.000321	0.00255	CcSEcCtD
Phylloquinone—Pain—Flunisolide—asthma	0.000315	0.0025	CcSEcCtD
Phylloquinone—Anaphylactic shock—Montelukast—asthma	0.000314	0.0025	CcSEcCtD
Phylloquinone—Hypersensitivity—Aminophylline—asthma	0.000311	0.00247	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Dexamethasone—asthma	0.000305	0.00242	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Betamethasone—asthma	0.000305	0.00242	CcSEcCtD
Phylloquinone—Dyspnoea—Mometasone—asthma	0.000305	0.00242	CcSEcCtD
Phylloquinone—Dizziness—Ipratropium bromide—asthma	0.000304	0.00242	CcSEcCtD
Phylloquinone—Anaphylactic shock—Salbutamol—asthma	0.000303	0.00241	CcSEcCtD
Phylloquinone—Hypotension—Formoterol—asthma	0.0003	0.00238	CcSEcCtD
Phylloquinone—Hypotension—Arformoterol—asthma	0.0003	0.00238	CcSEcCtD
Phylloquinone—Sweating increased—Prednisolone—asthma	0.000298	0.00237	CcSEcCtD
Phylloquinone—Dizziness—Fluticasone Propionate—asthma	0.000294	0.00234	CcSEcCtD
Phylloquinone—Dizziness—Salmeterol—asthma	0.000294	0.00233	CcSEcCtD
Phylloquinone—Anaphylactic shock—Budesonide—asthma	0.000294	0.00233	CcSEcCtD
Phylloquinone—Hypersensitivity—Tiotropium—asthma	0.000293	0.00233	CcSEcCtD
Phylloquinone—Hyperhidrosis—Salbutamol—asthma	0.000293	0.00233	CcSEcCtD
Phylloquinone—Pain—Mometasone—asthma	0.000292	0.00232	CcSEcCtD
Phylloquinone—Sweating increased—Hydrocortisone—asthma	0.000291	0.00231	CcSEcCtD
Phylloquinone—Dyspnoea—Arformoterol—asthma	0.000286	0.00227	CcSEcCtD
Phylloquinone—Dyspnoea—Formoterol—asthma	0.000286	0.00227	CcSEcCtD
Phylloquinone—Hyperhidrosis—Budesonide—asthma	0.000284	0.00225	CcSEcCtD
Phylloquinone—Hypotension—Salbutamol—asthma	0.000283	0.00225	CcSEcCtD
Phylloquinone—Dizziness—Aminophylline—asthma	0.000279	0.00222	CcSEcCtD
Phylloquinone—Pain—Arformoterol—asthma	0.000274	0.00218	CcSEcCtD
Phylloquinone—Pain—Formoterol—asthma	0.000274	0.00218	CcSEcCtD
Phylloquinone—Sweating increased—Triamcinolone—asthma	0.000274	0.00218	CcSEcCtD
Phylloquinone—Sweating increased—Methylprednisolone—asthma	0.000273	0.00217	CcSEcCtD
Phylloquinone—Hypersensitivity—Flunisolide—asthma	0.000272	0.00216	CcSEcCtD
Phylloquinone—Dyspnoea—Salbutamol—asthma	0.00027	0.00215	CcSEcCtD
Phylloquinone—Pain—Montelukast—asthma	0.000269	0.00214	CcSEcCtD
Phylloquinone—Dizziness—Loratadine—asthma	0.000263	0.00209	CcSEcCtD
Phylloquinone—Dizziness—Tiotropium—asthma	0.000263	0.00209	CcSEcCtD
Phylloquinone—Dyspnoea—Budesonide—asthma	0.000262	0.00208	CcSEcCtD
Phylloquinone—Pain—Salbutamol—asthma	0.000259	0.00206	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—IL6—asthma	0.000251	0.00528	CbGpPWpGaD
Phylloquinone—Pain—Budesonide—asthma	0.000251	0.00199	CcSEcCtD
Phylloquinone—Sweating increased—Dexamethasone—asthma	0.000248	0.00197	CcSEcCtD
Phylloquinone—Sweating increased—Betamethasone—asthma	0.000248	0.00197	CcSEcCtD
Phylloquinone—Dizziness—Flunisolide—asthma	0.000244	0.00194	CcSEcCtD
Phylloquinone—Sweating—Methylprednisolone—asthma	0.00024	0.0019	CcSEcCtD
Phylloquinone—Hypersensitivity—Formoterol—asthma	0.000236	0.00188	CcSEcCtD
Phylloquinone—Hypersensitivity—Arformoterol—asthma	0.000236	0.00188	CcSEcCtD
Phylloquinone—Hypersensitivity—Montelukast—asthma	0.000232	0.00184	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—ACE—asthma	0.000228	0.00478	CbGpPWpGaD
Phylloquinone—Hypersensitivity—Salbutamol—asthma	0.000223	0.00177	CcSEcCtD
Phylloquinone—Sweating increased—Prednisone—asthma	0.000216	0.00172	CcSEcCtD
Phylloquinone—Hypersensitivity—Budesonide—asthma	0.000216	0.00172	CcSEcCtD
Phylloquinone—Immune system disorder—Hydrocortisone—asthma	0.000216	0.00171	CcSEcCtD
Phylloquinone—Erythema—Prednisolone—asthma	0.000213	0.00169	CcSEcCtD
Phylloquinone—Dizziness—Arformoterol—asthma	0.000212	0.00169	CcSEcCtD
Phylloquinone—Dizziness—Formoterol—asthma	0.000212	0.00169	CcSEcCtD
Phylloquinone—Erythema—Hydrocortisone—asthma	0.000208	0.00165	CcSEcCtD
Phylloquinone—Dizziness—Montelukast—asthma	0.000208	0.00165	CcSEcCtD
Phylloquinone—Immune system disorder—Methylprednisolone—asthma	0.000203	0.00161	CcSEcCtD
Phylloquinone—Dizziness—Salbutamol—asthma	0.0002	0.00159	CcSEcCtD
Phylloquinone—Erythema—Triamcinolone—asthma	0.000196	0.00156	CcSEcCtD
Phylloquinone—Erythema—Methylprednisolone—asthma	0.000195	0.00155	CcSEcCtD
Phylloquinone—Dizziness—Budesonide—asthma	0.000194	0.00154	CcSEcCtD
Phylloquinone—Erythema—Dexamethasone—asthma	0.000178	0.00141	CcSEcCtD
Phylloquinone—Erythema—Betamethasone—asthma	0.000178	0.00141	CcSEcCtD
Phylloquinone—Anaphylactic shock—Prednisolone—asthma	0.000174	0.00138	CcSEcCtD
Phylloquinone—Anaphylactic shock—Hydrocortisone—asthma	0.00017	0.00135	CcSEcCtD
Phylloquinone—Hyperhidrosis—Prednisolone—asthma	0.000168	0.00133	CcSEcCtD
Phylloquinone—Flushing—Prednisone—asthma	0.000165	0.00131	CcSEcCtD
Phylloquinone—Hyperhidrosis—Hydrocortisone—asthma	0.000164	0.0013	CcSEcCtD
Phylloquinone—Immune system disorder—Prednisone—asthma	0.000161	0.00128	CcSEcCtD
Phylloquinone—Anaphylactic shock—Triamcinolone—asthma	0.00016	0.00127	CcSEcCtD
Phylloquinone—Anaphylactic shock—Methylprednisolone—asthma	0.00016	0.00127	CcSEcCtD
Phylloquinone—Hypotension—Hydrocortisone—asthma	0.000159	0.00126	CcSEcCtD
Phylloquinone—Erythema—Prednisone—asthma	0.000155	0.00123	CcSEcCtD
Phylloquinone—Hyperhidrosis—Triamcinolone—asthma	0.000155	0.00123	CcSEcCtD
Phylloquinone—Hyperhidrosis—Methylprednisolone—asthma	0.000154	0.00122	CcSEcCtD
Phylloquinone—Hypotension—Methylprednisolone—asthma	0.000149	0.00118	CcSEcCtD
Phylloquinone—Pain—Prednisolone—asthma	0.000149	0.00118	CcSEcCtD
Phylloquinone—Pain—Hydrocortisone—asthma	0.000145	0.00115	CcSEcCtD
Phylloquinone—Anaphylactic shock—Dexamethasone—asthma	0.000145	0.00115	CcSEcCtD
Phylloquinone—Anaphylactic shock—Betamethasone—asthma	0.000145	0.00115	CcSEcCtD
Phylloquinone—Dyspnoea—Triamcinolone—asthma	0.000143	0.00113	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—LEP—asthma	0.000141	0.00297	CbGpPWpGaD
Phylloquinone—Hyperhidrosis—Dexamethasone—asthma	0.00014	0.00111	CcSEcCtD
Phylloquinone—Hyperhidrosis—Betamethasone—asthma	0.00014	0.00111	CcSEcCtD
Phylloquinone—Pain—Triamcinolone—asthma	0.000137	0.00109	CcSEcCtD
Phylloquinone—Hypotension—Betamethasone—asthma	0.000136	0.00108	CcSEcCtD
Phylloquinone—Hypotension—Dexamethasone—asthma	0.000136	0.00108	CcSEcCtD
Phylloquinone—Hypersensitivity—Prednisolone—asthma	0.000128	0.00102	CcSEcCtD
Phylloquinone—Anaphylactic shock—Prednisone—asthma	0.000126	0.001	CcSEcCtD
Phylloquinone—Hypersensitivity—Hydrocortisone—asthma	0.000125	0.000994	CcSEcCtD
Phylloquinone—Pain—Dexamethasone—asthma	0.000124	0.000985	CcSEcCtD
Phylloquinone—Pain—Betamethasone—asthma	0.000124	0.000985	CcSEcCtD
Phylloquinone—Hyperhidrosis—Prednisone—asthma	0.000122	0.00097	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—POMC—asthma	0.000121	0.00255	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—CCL2—asthma	0.000119	0.0025	CbGpPWpGaD
Phylloquinone—Hypersensitivity—Triamcinolone—asthma	0.000118	0.000936	CcSEcCtD
Phylloquinone—Hypersensitivity—Methylprednisolone—asthma	0.000118	0.000933	CcSEcCtD
Phylloquinone—Dizziness—Prednisolone—asthma	0.000115	0.000913	CcSEcCtD
Phylloquinone—Dizziness—Hydrocortisone—asthma	0.000112	0.000892	CcSEcCtD
Phylloquinone—Dizziness—Triamcinolone—asthma	0.000106	0.00084	CcSEcCtD
Phylloquinone—Dizziness—Methylprednisolone—asthma	0.000105	0.000838	CcSEcCtD
Phylloquinone—Dizziness—Betamethasone—asthma	9.59e-05	0.000762	CcSEcCtD
Phylloquinone—Dizziness—Dexamethasone—asthma	9.59e-05	0.000762	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—CXCL8—asthma	9.4e-05	0.00197	CbGpPWpGaD
Phylloquinone—Hypersensitivity—Prednisone—asthma	9.31e-05	0.000739	CcSEcCtD
Phylloquinone—Dizziness—Prednisone—asthma	8.35e-05	0.000664	CcSEcCtD
